BLJ Pharmaceuticals Private Limited
About BLJ Pharmaceuticals Private Limited
Data last updated:
BLJ Pharmaceuticals Private Limited is a private limited company based in Dadri, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 27 August 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24232UP2008PTC213072.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rupali Jain and Pranjal Jain.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Dadri, Uttar Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹37.07 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹10.26 Lakh (net margin 27.7%) and EBITDA of ₹13.44 Lakh (EBITDA margin 36.2%). Revenue has grown at a compounded annual rate (CAGR) of 406% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
BLJ Pharmaceuticals has one previous CIN (Corporate Identification Number): U24232DL2008PTC182488. The current CIN is U24232UP2008PTC213072, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232UP2008PTC213072 | Current |
| U24232DL2008PTC182488 | Previous |
Contact details
BLJ Pharmaceuticals Private Limited's registered office is in Dadri, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot – 066 Kasna Ecotech – XI, Greater Noida, Dadri, Uttar Pradesh, India – 201306
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of BLJ Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of BLJ Pharmaceuticals is trade. In detail, this covers wholesale trading and retail trading. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | |
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of BLJ Pharmaceuticals Private Limited, buy the company report.
Financials of BLJ Pharmaceuticals Private Limited
FY 2025 filings availableBLJ Pharmaceuticals Private Limited reported revenue of ₹37.07 Lakh (up 1530% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 406% over three years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹13.44 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹10.26 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 36.2% | ||||
| Net Profit Margin | 27.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of BLJ Pharmaceuticals Private Limited, buy the company report.
Board of directors of BLJ Pharmaceuticals Private Limited
BLJ Pharmaceuticals has 2 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rupali Jain Also directs: Anekant Ventures Consultancy LLP, Gautam Budh Management Institute Private Limited, Gautam Budh Garments Private Limited and 5 more | Director | 26 Dec 2018 | 7 Years 10 Months | Current |
| Pranjal Jain Also directs: KJS Partners Legal LLP, Premium Park Global Private Limited, Anekant Re Management Services Private Limited and 2 more | Director | 20 Feb 2021 | 5 Years 8 Months | Current |
Peer comparison
BLJ Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cutichem Pharmaceutical Private Limited | ₹37.08 Lakh (FY 2025) | -73.0% | Gurgaon, Haryana, India | |||
| BLJ Pharmaceuticals Private Limitedthis company | ₹37.07 Lakh (FY 2025) | ₹10.26 Lakh | 27.7% | 1530.0% | Dadri, Uttar Pradesh, India | |
| Serene Health Care Private Limited | ₹36.97 Lakh (FY 2024) | -96.0% | Ahmedabad, Gujarat, India | |||
| Ashi Pharmaceuticals Private Limited | ₹36.95 Lakh (FY 2019) | -11.0% | Indore, Madhya Pradesh, India |
To see the full peer comparison of BLJ Pharmaceuticals Private Limited, buy the company report.
Auditor
BLJ Pharmaceuticals Private Limited is audited by RAVI RATHI & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAVI RATHI & CO | FY 2023 | 017646N |
Shareholding
The shareholding of BLJ Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of BLJ Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving BLJ Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for BLJ Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for BLJ Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
BLJ Pharmaceuticals Private Limited has 10 board changes on record since 2017: 2 appointments and 8 cessations. The latest: Pranjal Jain ceased to be Additional Director on 30 Nov 2021.
1 earlier event is in the company report.
Frequently asked questions
BLJ Pharmaceuticals is an active private limited company based in Dadri, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 27 August 2008 (18+ years old) and is registered under CIN U24232UP2008PTC213072.
BLJ Pharmaceuticals has 2 current directors:
- Rupali Jain - Director
- Pranjal Jain - Director
The latest financial statements of BLJ Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of BLJ Pharmaceuticals is U24232UP2008PTC213072. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
BLJ Pharmaceuticals was incorporated on 27 August 2008, making it 18+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of BLJ Pharmaceuticals by revenue are Cutichem Pharmaceutical Private Limited, Serene Health Care Private Limited, Ashi Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Pranjal Jain ceased to be Additional Director on 30 Nov 2021. Neeraj Rastogi ceased to be Director on 20 Feb 2021. Pranjal Jain was appointed as Director on 20 Feb 2021. BLJ Pharmaceuticals has 10 board changes on record in total.
The registered office of BLJ Pharmaceuticals is at Plot – 066 Kasna Ecotech – XI, Greater Noida, Dadri, Uttar Pradesh, India – 201306.
BLJ Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of BLJ Pharmaceuticals is compliant as of 08 August 2026. The company is actively filing with the Registrar of Companies.
BLJ Pharmaceuticals can be reached at its registered office: Plot – 066 Kasna Ecotech – XI, Greater Noida, Dadri, Uttar Pradesh, India – 201306.